The effect of continuous preperitoneal infusion of ropivacaine as postoperative analgesia in patients undergoing major abdominopelvic surgeries for resection of tumours

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12616001024437

Enrollment

Registered

2016-08-02

Start date

2015-05-15

Completion date

2015-12-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Postoperative pain after major abdoiminal and pelvic operation is a challenging issue. the ideal method of pain control is by inserting epidural catheter. But preperitonial catheter insertion is a new technique .So this study will be conducted to compare between two different techniques in control of pain postoperative.

Interventions

The patients will be divided into two groups .The first groups will receive continuous epidural infusion for analgesia and the second groups will receive continuous preperitoneal infusion for analgesia. The intervention group is the preperitoneal group in which a multiholed catheter will be placed by surgeon in the preperitoneal space at the end of surgery giving ropivacaine 0.5% 5ml/h by continuous infusion for 48 hours postoperative after giving bolus dose of 15 ml of lidocaine 2%

Study design

Allocation

Randomised controlled trial

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

1-ASA status 1 ,2,or three 2-aged between 20-80 years old 3-both sexes 4-patients scheduled for abdominal or pelvic resection of tumours

Exclusion criteria

1-patients refusal 2-allergy to local anesthetics 3-bleeding diathesis 4-patients on previous opioid therapy 5- Patients with psychiatric disorders

Outcome results